After NASH patients received 1 year of lifestyle intervention to achieve weight loss, transcript levels of SPTLC2 and CERS1 in the liver were significantly reduced compared to controls without lifestyle intervention, and ceramide synthesis levels were reduced, reversing the NASH process 163. Here, SPTLC2 is linked to metabolic dysfunction-associated steatohepatitis.